Screening of biomarkers using micro/nanoarrays for diagnostics of neurodegenerative diseases
Public support
Provider
Ministry of Education, Youth and Sports
Programme
KONTAKT II
Call for proposals
KONTAKT II 2 (SMSM2012LH2)
Main participants
ESSENCE LINE, s.r.o.
Contest type
VS - Public tender
Contract ID
MSMT-6805/2013-311
Alternative language
Project name in Czech
Screening biomarkerů pomocí mikro/nanočipů pro diagnózu neurodegenerativních nemocí
Annotation in Czech
Cílem tohoto projektu je získat nové soubory biomarkerů ukotvených na microarrays, které budou sestaveny tak, aby poskytly nové poznatky měřením hladin těchto biomarkerů v klinických vzorcích nebo vzorcích animálních modelů. Prioritou je získat takové poznatky, které by připěly k nové diagnostice, případně k terapii těchto chorob.
Scientific branches
R&D category
ZV - Basic research
CEP classification - main branch
CB - Analytical chemistry, separation
CEP - secondary branch
EI - Biotechnology and bionics
CEP - another secondary branch
FH - Neurology, neuro-surgery, nuero-sciences
OECD FORD - equivalent branches <br>(according to the <a href="http://www.vyzkum.cz/storage/att/E6EF7938F0E854BAE520AC119FB22E8D/Prevodnik_oboru_Frascati.pdf">converter</a>)
10406 - Analytical chemistry<br>20801 - Environmental biotechnology<br>20802 - Bioremediation, diagnostic biotechnologies (DNA chips and biosensing devices) in environmental management<br>20803 - Environmental biotechnology related ethics<br>20901 - Industrial biotechnology<br>20902 - Bioprocessing technologies (industrial processes relying on biological agents to drive the process) biocatalysis, fermentation<br>20903 - Bioproducts (products that are manufactured using biological material as feedstock) biomaterials, bioplastics, biofuels, bioderived bulk and fine chemicals, bio-derived novel materials<br>30103 - Neurosciences (including psychophysiology)<br>30210 - Clinical neurology<br>30401 - Health-related biotechnology<br>30402 - Technologies involving the manipulation of cells, tissues, organs or the whole organism (assisted reproduction)<br>30403 - Technologies involving identifying the functioning of DNA, proteins and enzymes and how they influence the onset of disease and maintenance of well-being (gene-based diagnostics and therapeutic interventions [pharmacogenomics, gene-based therapeutics])<br>30404 - Biomaterials (as related to medical implants, devices, sensors)<br>30405 - Medical biotechnology related ethics<br>40401 - Agricultural biotechnology and food biotechnology<br>40402 - GM technology (crops and livestock), livestock cloning, marker assisted selection, diagnostics (DNA chips and biosensing devices for the early/accurate detection of diseases) biomass feedstock production technologies, biopharming<br>40403 - Agricultural biotechnology related ethics
Completed project evaluation
Provider evaluation
U - Uspěl podle zadání (s publikovanými či patentovanými výsledky atd.)
Project results evaluation
In 2015, newly designed matrices and modified contemporary bioinformatic methods were applied to measuring marker levels in selected studies of neurodegenerative processes. The results have been published in expert media.
Solution timeline
Realization period - beginning
Mar 1, 2012
Realization period - end
Dec 31, 2015
Project status
U - Finished project
Latest support payment
Feb 27, 2015
Data delivery to CEP
Confidentiality
S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů
Data delivery code
CEP16-MSM-LH-U/01:1
Data delivery date
Oct 9, 2017
Finance
Total approved costs
2,992 thou. CZK
Public financial support
2,142 thou. CZK
Other public sources
0 thou. CZK
Non public and foreign sources
850 thou. CZK